Cargando…
Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide
Autores principales: | Cebon, J, Findlay, M, Hargreaves, C, Stockler, M, Thompson, P, Boyer, M, Roberts, S, Poon, A, Scott, A M, Kalff, V, Garas, G, Dowling, A, Crawford, D, Ring, J, Basser, R, Strickland, A, Macdonald, G, Green, M, Nowak, A, Dickman, B, Dhillon, H, Gebski, V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360136/ http://dx.doi.org/10.1038/sj.bjc.6603674 |
Ejemplares similares
-
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide
por: Cebon, J
Publicado: (2006) -
Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
por: Nilsson, O., et al.
Publicado: (1998) -
Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.
por: Macaulay, V. M., et al.
Publicado: (1991) -
Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors
por: Abdellatif, Ahmed A. H., et al.
Publicado: (2020) -
Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax
por: Yin, Rong, et al.
Publicado: (2017)